Audacia strengthens its Board of Directors with the arrival of Sébastien Aguettant
9 December 2024 • Private Equity • Back to news
Audacia announces the arrival of Sébastien Aguettant, President of the Delpharm Group, on its Board of Directors.
Already a shareholder of Audacia, Sébastien Aguettant is strengthening his commitment by doubling his stake, which increases from 2% to 4%, thanks to the acquisition of shares from Gravitation, Audacia’s majority shareholder. This investment demonstrates his great confidence in the development of the group and its ability to create value in the future.
Find the Press Release on this link.